ArticleNPJ precision oncology2024
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials.
Arnaud Bayle et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it